Mergers & Acquisitions


Current filters:


Popular Filters

826 to 850 of 895 results

Angiotech opts out of cardiovascular cell therapy program with Athersys


Regenerative medicines firm Athersys (Nasdaq: ATHX) says that Canada’s Angiotech Pharmaceuticals…

AngiotechAthersysBiotechnologyFinancialLicensingMergers & Acquisitions

Japanese pharma companies set to go global - by P Reed Maurer


In a short time much can change in Japan. A striking example is the move by Japanese pharmaceutical companies…

Asia-PacificLicensingMergers & AcquisitionsPharmaceutical

Salix Pharma to buy Oceana for $300 million; posts 3rd-qtr profit


With the aim of improving its innovate products franchise, US drugmaker Salix Pharmaceuticals (Nasdaq:…

FinancialMergers & AcquisitionsOceana TherapeuticsPharmaceuticalSalix Pharmaceuticals

Synthes acquisition by Johnson & Johnson delayed as EU Commission starts in-depth investigation


The planned $21.3 billion acquisition of orthopedic device maker Synthes (SYST: VX), which is listed…

Johnson & JohnsonMergers & AcquisitionsPharmaceuticalSynthes

Ipsen sells North American rights for Apokyn to Britannia Pharma


French drugmaker Ipsen (Euronext: IPN) today has sold its North American development and marketing rights…

ApokynBritannia PharmaceuticalsIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSTADA Arzneimittel

SurModics to sell pharmaceutical assets to Evonik for $30 million


USA-based SurModics (Nasdaq: SRDX), a provider of surface modification technologies to the healthcare…

Evonik InternationalMergers & AcquisitionsPharmaceuticalSurModics

Karo Bio to spin off preclinical development


In order to achieve better allocation of resources and competences, Swedish biotech firm Karo Bio (STO:…

BiotechnologyKaro BioMergers & AcquisitionsResearch

Biostar Pharma sets out targets as it completes buy of Shaanxi Weinan


Chinese drugmaker Biostar Pharmaceuticals (Nasdaq: BSPM) says that it has completed the previously-announced…

Asia-PacificBiostar PharmaGenericsMergers & AcquisitionsShaanxi Weinan

Arrowhead acquires RNA assets and site from Roche, which takes minority stake in the firm


California, USA-based Arrowhead Research Corp Nasdaq: ARWR) said yesterday that it has acquired RNA therapeutics…

Arrowhead ResearchFinancialMergers & AcquisitionsPharmaceuticalRoche

Immdal sells Newport to Ewopharma; establishes Immcell


Privately-held Irish drugmaker Immdal last week announced the sale of its subsidiary Newport Pharmaceuticals…

Anti-viralsEwopharmaImmdalMergers & AcquisitionsNewport PharmaPharmaceutical

Sun Pharma offers to acquire remainder of Taro shares


Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

GlaxoSmithKline may be ready to acquire Human Genome, newspaper reports


Shares of the UK’s biggest pharmaceuticals group, GlaxoSmithKline (LSE: GSK) amid revived speculation…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Angel Biotech proposes joint venture with Russia’s Materia Medica


Scotland-based Angel Biotechnology (ABH: LON) saw its shares leap 20% to 0.28 pence on Monday after it…

Angel BiotechnologyBiotechnologyEuropeMateria MedicaMergers & Acquisitions

Roche to boost hep C offerings with $230 million acquisition of Anadys Pharma


In a further move to broaden in presence outside its current domination in the oncology sector, Swiss…

Anadys PharmaceuticalsAnti-viralsMergers & AcquisitionsPharmaceuticalRoche

826 to 850 of 895 results

Back to top